Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomography

European Journal of Nuclear Medicine

Volumn 24, Issue 2, 1997, Pages 192-196

  Chiti, Arturo ^a   Agresti, Roberto ^a   Maffioli, Lorenzo S ^a   Tomasic, Gorana ^a   Savelli, Giordano ^a   Crippa, Flavio ^a   Pilotti, Silvana ^a   Greco, Marco ^a   Bombardieri, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Axillary lymph nodes; Breast cancer; Indium 111 pentetreotide; Technetium 99m sestamibi

Indexed keywords

INDIUM 111; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TOMOGRAPHY;

AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; EVALUATION STUDIES; FEMALE; HUMANS; INDIUM RADIOISOTOPES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030999787     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02439552     Document Type: Article

References (11)

1. Kolscielny S, Le Mg, Tubiana M. The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases. Br J Cancer 1989; 59: 775-782.
2. Menard S, Bufalino R, Rilke F, et al. Prognosis based on primary breast carcinoma instead of pathological nodal status. Br J Cancer 1994; 70: 709-712.
3. Chada M, Chabon AB, Friedmann P. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariable analysis. Cancer 1994; 73: 350-353.
4. Crippa F, Agresti R, Bombardieri E, et al. Preliminary results of pre-operative axillary radioimmunoscintigraphy with In-111 B72.3 in breast cancer. Int J Oncol 1995; 6: 791-795.
5. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
6. 99mTc-SestaMIBI SPET. J Nucl Med 1996; 37: 938-942.
7. Maffioli LS, Gasparini M, Chiti A, et al. Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumors. Eur J Nucl Med 1996; 23: 308-311.
8. Khalkhali I, Mena I, Jouanne E. Prone scintimammography in patients with suspicions of carcinoma of the breast. J Am Coll Surg 1994; 178: 491-497.
9. Ell PJ. Keeping abreast of time. Eur J Nucl Med 1995; 22: 967-969.
10. Van Eijck CHJ, Krenning EP, Bootsma A, et al. Somatostatin-receptor scintigraphy in primary breast cancer. Lancet 1994; 343: 630-643.
11. Chin ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile)-technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.